At a glance
ClinicalIndex Comparison RecordN/ACompleted· 268 enrolled
Drug / intervention
Robotic pancreaticoduodenectomy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors: A Multicenter Phase III Non-Inferiority Randomized Controlled Trial
In Brief
A clinical study evaluating Robotic pancreaticoduodenectomy and Open pancreaticoduodenectomy for Pancreatic Adenocarcinoma and 6 related conditions. Completed, enrolled 268 participants across 1 site.
Detailed Summary
This multicenter randomized trial aims to primarily assess and compare the functional recovery of patients who undergo open versus robotic pancreaticoduodenectomy for benign and malignant lesions of the head of the pancreas.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Adenocarcinoma, Pancreatic Cysts, Pancreatic Endocrine Tumors, Chronic Pancreatitis, Cholangiocarcinoma, Extrahepatic, Ampullary Adenocarcinoma, Duodenal Adenocarcinoma
CountriesChina
CollaboratorsIntuitive Surgical
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMay 2020
Enrollment StartSep 2020
Primary CompletionNov 2024
Study CompletionFeb 2025
TodayJul 2026
First PostedMay 22, 2020
Enrollment StartSep 28, 2020
Primary CompletionNov 28, 2024
Study CompletionFeb 28, 2025
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 6.1 years ago
Interventions
Robotic pancreaticoduodenectomyprocedure
Patients in this arm will undergo a pancreaticoduodenectomy with robotic-assisted techonology.
Open pancreaticoduodenectomyprocedure
Patients in this arm will undergo an open pancreaticoduodenectomy which is the standard surgical approach.